🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sorafenib may stop the growth of tumor cells by blocking some of the enzyme...
Status
Terminated
Location
Duke University Medical Center
Start Date
2004-10
Trial ID
NCT00098618
Treatments Being Tested
The purpose of the study is to: * Find out if patients receiving BAY43-900...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00117637
Treatments Being Tested
RATIONALE: PEG-interferon alfa-2b may interfere with the growth of tumor ce...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2008-02
Trial ID
NCT00589550
Sequential therapy with BEvacizumab, RAd001 (everolimus) and Tyrosinekinase...
Status
Completed
Location
Charité Berlin
Start Date
2012-10
Trial ID
NCT01731158
Treatments Being Tested
The primary objective of this prospective, observational, post-marketing st...
Status
Terminated
Location
Multiple Locations
Start Date
2010-12-13
Trial ID
NCT01195649
Treatments Being Tested
The purpose of this study is to see if taking interferon or gemcitabine alo...
Status
Terminated
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00352859
This study is to assess sorafenib as second treatment for patients that hav...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00678288
Treatments Being Tested
This phase II trial is studying how well giving sorafenib with interferon a...
Status
Completed
Location
Southwest Oncology Group
Start Date
2004-09
Trial ID
NCT00101114
Treatments Being Tested
This randomized phase II trial is studying sorafenib and interferon alfa-2b...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2005-06
Trial ID
NCT00126594
Treatments Being Tested